TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the quarter ended June 30, 2021.
Mr. Kåre Schultz, Teva’s President and CEO, said, We have performed well in the second quarter, improving…

Click here to view the original article.